Search results
Placing COVID patients in skilled nursing facilities led to increased cases, deaths, study finds
Center for Infectious Disease Research and Policy· 6 hours agoOutcomes were assessed during a 15-week follow-up period. The authors found that exposed SNFs had a...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 23 hours agoIn ACE-Breast-02, ARX788 managed to prolong progression-free survival (PFS) compared to LC, with...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoThese safety results are in keeping with the known toxicities of Enhertu and Perjeta....
Infarct size does not affect treatment effect of early versus late direct oral anticoagulant...
Medical Xpress· 7 days agoFor individuals with minor, moderate, or major stroke, the treatment effect of early versus late...
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 2 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, presented updated clinical ...
Early use of antivirals linked to reduced risk of long COVID
Center for Infectious Disease Research and Policy· 1 day agoOverall early oral antiviral drugs reduced long-COVID risk 23% (risk ratio [RR] 0.77; 95% confidence...
N95 respirator gets top billing in stopping SARS-CoV-2 viral leakage into the air
Center for Infectious Disease Research and Policy· 13 hours agoResearchers who compared the ability of cloth and surgical masks and KN95 and N95 respirators to...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoTelix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and ...
ASCO 24: Data shows survival benefit with J&J’s subcutaneous Rybrevant
Clinical Trials Arena via Yahoo Finance· 3 days agoAdditionally, the median PFS benefit of the SC formulation, was 6.1 months vs 4.3 months (hazard...
Council Post: What Leaders Can Learn From Modern Anti-Money Laundering Techniques
Forbes· 2 days agoAshley Stephenson is the CTO of Corero Network Security, a leading provider of DDoS protection...